<DOC>
	<DOCNO>NCT01025284</DOCNO>
	<brief_summary>Part A : This study evaluate experimental treatment patient extensive-disease small-cell lung cancer . Part B : This study evaluate experimental treatment patient extensive-disease small-cell lung cancer .</brief_summary>
	<brief_title>A Study Patients With Small-Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<criteria>Have histological cytological evidence extensivedisease smallcell lung cancer Have presence measurable disease define Response Evaluation Criteria Solid Tumors ( RECIST 1.1 ) Have receive least 1 prior chemotherapy regimen agent know provide clinical benefit smallcell lung cancer , opinion investigator , appropriate candidate experimental therapy Have discontinue previous therapy cancer , include chemotherapy , biologic therapy , hormone therapy , radiotherapy . Patients must recover acute effect therapy ( except alopecia fatigue ) study enrollment Part A : Have performance status 0 2 Eastern Cooperative Oncology Group scale Part B : Have performance status 0 1 Eastern Cooperative Oncology Group scale Have receive treatment within 28 day first dose LY2523355 drug receive regulatory approval indication Have mix histological diagnosis smallcell lung cancer nonsmallcell lung cancer Have serious preexist medical condition , opinion investigator , would preclude participation study Part A : Have symptomatic , untreated , uncontrolled central nervous system ( CNS ) metastasis . Patients treat CNS metastasis eligible provided disease radiographically stable , asymptomatic , corticosteroid use discontinue least 2 week prior first dose study drug . Screening asymptomatic patient without history CNS metastasis require Part B : Have symptomatic , untreated , uncontrolled central nervous system ( CNS ) metastases history CNS metastasis . Patients receive prophylactic radiation exclude . Screening asymptomatic patient without history CNS metastases require</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>